Open Access

Ned-19 inhibition of parasite growth and multiplication suggests a role for NAADP mediated signalling in the asexual development of Plasmodium falciparum

Contributed equally
Malaria Journal201716:366

https://doi.org/10.1186/s12936-017-2013-7

Received: 15 March 2017

Accepted: 4 September 2017

Published: 12 September 2017

Abstract

Background

Although malaria is a preventable and curable human disease, millions of people risk to be infected by the Plasmodium parasites and to develop this illness. Therefore, there is an urgent need to identify new anti-malarial drugs. Ca2+ signalling regulates different processes in the life cycle of Plasmodium falciparum, representing a suitable target for the development of new drugs.

Results

This study investigated for the first time the effect of a highly specific inhibitor of nicotinic acid adenine dinucleotide phosphate (NAADP)-induced Ca2+ release (Ned-19) on P. falciparum, revealing the inhibitory effect of this compound on the blood stage development of this parasite. Ned-19 inhibits both the transition of the parasite from the early to the late trophozoite stage and the ability of the late trophozoite to develop to the multinucleated schizont stage. In addition, Ned-19 affects spontaneous intracellular Ca2+ oscillations in ring and trophozoite stage parasites, suggesting that the observed inhibitory effects may be associated to regulation of intracellular Ca2+ levels.

Conclusions

This study highlights the inhibitory effect of Ned-19 on progression of the asexual life cycle of P. falciparum. The observation that Ned-19 inhibits spontaneous Ca2+ oscillations suggests a potential role of NAADP in regulating Ca2+ signalling of P. falciparum.

Keywords

Ned-19 NAADP Malaria Calcium signalling Plasmodium falciparum NAADP receptor Antimalarial drugs P. falciparum development

Background

With 3.3 billion of people at risk to be infected and an estimated death toll of 429,000 in 2015 [1] malaria remains a great threat in tropical countries. Artemisinin combination therapies, although highly effective, have met with the development of parasite resistance in recent years, exacerbating the need for the identification of new anti-malarial drugs [2].

In Plasmodium falciparum, Ca2+ signalling regulates different physiological processes involved in the life cycle of parasite, such as erythrocyte invasion [3, 4], merozoite egress from the infected erythrocyte [5] and parasite development [6]. As well as in higher eukaryotic cells, different Ca2+ stores have been found in Plasmodium: endoplasmic reticulum, acidocalcisomes, mitochondria and the digestive vacuole. Acidocalcisomes are acidic organelles rich in Ca2+ and other cations bound to phosphate polymers. A Ca2+-ATPase, a bafilomycin-sensitive vacuolar V-H+-ATPase, a V-H+-PPase and a Ca2+–H+ antiporter localize on the membrane of these organelles, regulating Ca2+ balance [7]. It has been proposed that another acidic organelle of P. falciparum, the food vacuole, could be a Ca2+ store sensitive to thapsigargin, bafilomycin and NH4Cl [8]. Ca2+ homeostasis in Plasmodium is mainly regulated by two Ca2+-ATPase, the thapsigargin-insensitive PfATP4 [9] and the thapsigargin-sensitive sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) orthologue PfATP6 [10]. Scheibel and co-workers showed that both Ca2+ and calmodulin antagonists inhibit the growth of P. falciparum [11]. Moreover, the identification of SERCA as a target of artemisinins [10] highlights the crucial role of Ca2+ signalling in the life cycle of the parasite.

In higher eukaryotic cells, different intracellular second messengers finely regulate the spatio-temporal fluctuation of cytosolic Ca2+ concentration, mobilizing calcium from different intracellular stores. Inositol 1,4,5-bisphosphate (IP3) [12], cyclic ADP-ribose (cADPR) [13] and nicotinic acid adenine dinucleotide phosphate (NAADP) [14] have been so far identified as Ca2+-mobilizing second messengers in higher eukaryotic cells. The second messenger NAADP was described for the first time as a potent Ca2+ mobilizing agent in sea urchin eggs [14] and subsequently in ascidian and starfish oocytes [15, 16], in plants [17] and in higher eukaryotic cells [1821], suggesting a highly conserved feature in evolution for this molecule.

In Apicomplexa, second messengers involved in Ca2+ mobilization from intracellular organelles have been poorly investigated. At present only a few works have investigated the role of IP3 and cADPR in Ca2+ release in P. falciparum [2224] and none focused on NAADP, possibly for the absence in the parasite genome of sequences homologous to the putative two pore channels (TPCs) NAADP-receptor. Recently, Ned-19 has been identified by virtual screening as a specific inhibitor of NAADP-induced calcium signalling in sea urchin eggs and pancreatic beta cells, and was shown to bind NAADP receptors as a fluorescent probe [25]. Subsequently, Ned-19 mediated Ca2+ signalling inhibition and its biological effects have been reported in different mammalian cells. Ned-19 has been shown to inhibit histamine-induced secretion of von Willebrand factor (vWF) in endothelial cells [20], endothelin-1 (ET-1)-induced contraction of smooth muscle cells [26], NAADP-induced acrosome reaction in mammalian spermatozoa [27] and exocytosis of cytolytic granules in cytotoxic T Lymphocytes and VEGF-induced neoangiogenesis [28, 29].

The aim of this study was to investigate the effect of Ned-19 on the blood stage development of P. falciparum. Results show for the first time that Ned-19 specifically impairs both the growth and the ability to transform into multinucleate schizonts of the asexual trophozoite stages, suggesting a crucial role of NAADP in life cycle progression. This work also shows that Ned-19 inhibits spontaneous Ca2+ oscillations in early ring and trophozoite stages, which also suggests an important role of NAADP in Ca2+ homeostasis of P. falciparum.

Methods

Plasmodium falciparum parasites and cultures

Parasites from clone 3D7 [30] were cultured in 0+ human red blood cells at 5% haematocrit in RPMI 1640 plus hypoxanthine 50 mg/mL, HEPES 25 mM, 0.225% sodium bicarbonate and 10 mg/mL gentamicin, supplemented with 10% heat inactivated human serum. Parasites were kept at 37 °C, in a 2% O2, 5% CO2 and 93% N2 atmosphere. Percoll cushion and sorbitol treatment for parasite synchronization were performed as described [31, 32] previously. In parasite synchronization, sorbitol treatment of newly invaded parasites from Percoll purified schizonts was performed 3 h after Percoll treatment to obtain a parasite synchronization window of maximum 3 h. For gametocyte production, asynchronous parasites were grown to high parasitaemia (>8%) and culture medium was doubled at this point. The day after, 50 mM N-acetylglucosamine was added to medium and maintained for 3 days, until no asexual parasites were detected in the culture. Stage II gametocytes were detected 48 h after the addition of N-acetylglucosamine, while mature stage V appeared from 9 days after the treatment.

Parasitaemia was measured through Giemsa staining of culture blood smears (counting of at least 2000 RBCs) or FACS using CYBRGreen staining as previously described (counting of at least 50,000 cells) [33]. FACSAria I (BD Biosciences, Erembodegem, Belgium) equipped with three lasers (488, 635 and 407 nm violet solid state laser) was used to determine parasitaemia to a precision of 0.1%. The results were analyzed by BD FACSDiva Software version 6.1.3 (BD Biosciences).

Ned-19 and Ned-20 treatments

Ned-19 (Tocris bioscience) was resuspended in a stock solution of sterile dimethyl sulfoxide (DMSO) at 100 mM and kept at −20 °C until added to the Plasmodium cultures at the specified concentrations. In the case of Ned-20 the stock solution was kindly provided by Grant Churchill (Oxford University) at 10 mM and kept at −20 °C until use. Control cultures were incubated with a DMSO concentration equivalent to that of the treated cultures. Differences in parasitaemia between treated and untreated cultures were evaluated through Student’s t test.

Microscopy

Parasite cultures were incubated with 200 μM Ned-19 and 1 μM Lysotracker Green DND-26 (ThermoFisher Scientific) for 30 min at 37 °C in agitation and observed with a fluorescence microscope. A Zeiss Observer.Z1 inverted microscope was used to visualize live samples. Images were acquired using a Zeiss AxioCam MRm Rev. 3 FireWire camera through a Zeiss C-Apochromat 63x/1, 20 objective. Filters used to detect fluorescence were EX: 365–395, EM: 445–450 (Ned-19) and EX: 440–470, EM: 525–550 (Lysotracker Green DND-26). Giemsa-stained smears were examined to confirm stages of the synchronized parasites: proportions >90% of trophozoites, schizonts and ring forms were, respectively, observed at 32, 46 and 48 h after synchronization.

Electron microscopy

Parasite culture samples enriched in infected red blood cells by MACS (Magnetic-activated cell sorting) were fixed overnight in cold 2.5% glutaraldehyde in 0.1 M cacodylate buffer, postfixed in 2% osmium tetroxide for 2 h and treated for 30 min with 1% tannic acid in 0.05 M cacodylate buffer. Pellets were then dehydrated in ethanol and processed for Epon embedding. Ultrathin sections were contrasted in lead hydroxide and analyzed in a Hitachi 7000 transmission electron microscope.

Calcium imaging

In Ca2+ imaging experiments, protocol was adapted from [6], using the ratiometric Fura-2-AM as calcium reporter. Samples from cultures at high parasitaemia (5–10%) of the desired parasite stage were generated through parasite synchronization as follows: for early rings, parasites were harvested 50 h after the initial Percoll treatment, while for early trophozoites parasites were harvested 26 h after Percoll treatment. Cultures where then washed in BSA− medium for Ca2+ imaging (RPMI 1640 medium without phenol red supplemented with 25 mM HEPES, 24 mM sodium bicarbonate, 0.5 g/L l-glutamine and 50 mg/L hypoxanthine) and resuspended at 5% haematocrit in loading medium [BSA− medium supplemented with 1:100 PowerLoad (ThermoFisher Scientific)] with 3 μM Fura-2-AM (ThermoFisher Scientific) at 37 °C for 150 min in agitation. Loading medium was then washed away and cells were resuspended at 2.5% haematocrit in BSA+ medium [BSA− medium supplemented with 0.5% Albumax I and 25 mg/mL gentamicin (Sigma)]. Ned-19 100 μM or 0.1% DMSO was added to 1 mL of this cell suspension. This was plated in glass-bottomed 30 mm dishes previously coated with poly-l-lysine and incubated in a 2% O2, 5% CO2 and 93% N2 atmosphere for 45 min. Unbound cells were washed by gently rinsing the surface of the plate and substituting supernatant with BSA+ medium with Ned-19 or DMSO. Medium volume was then adjusted to 1 mL of BSA+ with Ned-19 or DMSO. This treatment resulted in cells treated with Ned-19 or DMSO for at least 45 min prior to the beginning of measurements, and the Ned-19 and DMSO treatments being kept during calcium imaging.

Ca2+ mobilization was measured in presence or absence of Ned-19. Plates with Fura-2-loaded cells were placed into a culture chamber at 37 °C on the stage of an inverted fluorescence microscope (Nikon, TE2000E), connected to a cooled CCD camera (512B Cascade, Princeton Instruments, AZ). Samples were illuminated alternately at 340 and 380 nm using a random access monochromator (Photon Technology International, NJ) and emission was detected using a 510 nm emission filter. Images (1 set of emission at 340 and 380 nm every 1.5 s) were acquired using Metafluor software (Universal Imaging Corporation, Downingtown, PA).

Images were analysed by generating square 4 × 4 mm ROIs (region of interest) encompassing a single parasite and recording the intensity of the emission for the ROI at 340 and 380 nm. Background was normalized for each ROI using a ROI the size of the full image, and ratio (R) was calculated as F(340)/F(380) for each ROI and time-point, obtaining time-courses for each ROI. R values were then normalized as R/Rmin−1.

OCTAVE free software with the script findpeaksfit.m by T.C. O’Haver [34] was used to identify and measure height of peaks, given as R/Rmin−1 values. Oscillation series were subdivided into fragments of 100 s each and script was run with settings as follows: x, y, SlopeThreshold = 0.0005, AmpThreshold = 0, smoothwide = 3, peakgroup = 3, smoothtype = 3, peakshape = 1, extra = 0, NumTrials = 0, autozero = 1, fixedparameters = 0, plots = 0. Differences between the height of peaks in DMSO and Ned-19 treated parasites were evaluated through unpaired Student’s t test analysis. For DMSO treated rings, N (number of time-courses) = 6, n (total number of peaks detected) = 622. For Ned-19 treated rings, N = 6, n = 265. In the case of trophozoites, for DMSO treated parasites N = 8, n = 349, for Ned-19 treated parasites N = 3, n = 150.

Results

Ned-19 inhibits the asexual development of Plasmodium falciparum

To determine whether the highly selective NAADP antagonist Ned-19 affected the asexual cycle of P. falciparum, the effects of this compound and of its inactive analogue Ned-20, unable to inhibit NAADP-mediated Ca2+ release in other organisms [35], were evaluated on synchronized early asexual stages of parasite clone 3D7, which were incubated for 48 h in the presence of Ned-19, Ned-20 or DMSO (100 μM). The parasitaemia of the culture incubated with Ned-19 showed a fivefold reduction compared to the DMSO-treated parasites. In contrast, the Ned-20 treated culture did not show a significant reduction in parasitaemia, supporting the specificity of Ned-19 in impairing the parasite asexual growth (Fig. 1b). Additional experiments showed that Ned-19 impairs parasite growth in a dose-dependent manner (Fig. 1c).
Fig. 1

Ned-19 specific blockage of P. falciparum asexual growth. a Structure of Ned-19 and of its inactive analogue Ned-20, adapted from Rosen et al. b Synchronous early ring stage parasites (initial parasitaemia 0.16%) were cultured for 48 h in the presence of 100 μM concentration of the indicated compounds. At the end of the incubation, parasitaemias were measured through Giemsa-stained preparations. Parasitaemia of the DMSO treated culture (1.08%) was set as 1. N = 3. ***p < 0.001. Error bar SEM. c Late asexual parasites (24 h post invasion, initial parasitaemia 1%) were cultured with the indicated concentrations of Ned-19 for 24 h. Parasitaemia was then measured through FACS counting of at least 50.000 cells per sample. N = 2. *p < 0.05; ***p < 0.001; ****p < 0.0001. Error bar range/2

Ned-19 blocks development of early trophozoites and prevents schizont maturation

To pinpoint the stage(s) of the parasite life cycle affected by Ned-19, a time course spanning one parasite asexual cycle was performed. A tightly synchronized culture of newly invaded ring stage parasites (synchronization window of 3 h) was produced and treated as described in Fig. 2. A control subculture was exposed to DMSO (subculture 1), one was treated with 100 μM Ned-19 for the entire cycle (subculture 2), one for the initial 8 h only (subculture 3), and in five additional subcultures (4–8) Ned-19 was added at 8 h intervals, at 8, 16, 24, 32 and 40 h of the parasite asexual development.
Fig. 2

Ned-19 activity on different stages of the P. falciparum asexual cycle. Synchronized ring stage parasites (initial parasitaemia 1.4%) were used to yield subcultures, numbered 1–8, which were incubated with DMSO control (blue line) or exposed to 100 μM Ned-19 (red line) at different times of the parasite asexual cycle. a Stages of the parasite asexual cycle. Black arrows indicate times at which the cultures were sampled. b Histograms showing parasitaemia and distribution of the different parasite stages for the cultures in each time-point. ER early rings, LR late rings, ET early trophozoites, LT late trophozoites, ES early schizonts, LS late schizonts. A representative sample of these forms is shown in Additional file 2: Figure S2

Parasite numbers and morphology were determined in Giemsa stained smears at all time points of all subcultures. Results indicated that presence of Ned-19 limited to the first 8 h after parasite invasion, at the very early ring stage parasites (subculture 3), or after 40 h, at the late schizont stage (subculture 8), did not affect the completion of the life cycle and the invasion of new red blood cells by the merozoites produced in schizogony. In contrast, parasite development was affected if Ned-19 was present between 8 and 40 h post-invasion. Timing and length of Ned-19 exposure were associated to some differences in the effects on the treated parasites. When ring stage parasites were exposed to Ned-19 from 0, 8, or 16 h post-invasion (subcultures 2, 4 and 5), their development did not progress beyond the early trophozoite stages, which accumulated and were observable for the remaining 48 h. When Ned-19 was added later in the asexual cycle, from 24 or 32 h of development (subcultures 6 and 7), the treated early trophozoite stages did not progress in development and accumulated as early schizonts. In subculture 7 a decrease in parasite number was also observed, indicating that incubation of Ned-19 with late trophozoite stages led to parasite cell disruption, unlike it was observed when Ned-19 was incubated with the ring stage parasites.

This experiment indicates that short-term exposure of parasites at the very early phase of the asexual cycle to Ned-19 is not sufficient to block development and, later in the cycle, Ned-19 does not directly affect schizogony and merozoite reinvasion. Ned-19 inhibitory activity is instead concentrated in the trophic part of the asexual cycle and in the development of the trophozoite into the schizont, suggesting that Ned-19 affects distinct cellular processes in the ring and in the trophozoite stages of the asexual parasite.

To pinpoint the time at which Ned-19 blocks late asexual development, tightly synchronized late trophozoite stages (32 h after synchronization) were treated with 100 μM Ned-19 at different times spanning a period from 12 h before to 2 h after schizogony, which occurred 44 h after invasion in the untreated control culture (Fig. 3). Parasite morphology and the number of ring stages resulting from successful merozoite reinvasion were measured. The experiment showed that Ned-19 treatment at 12, 10, 8 and 6 h before schizogony resulted in a low number of rings in the next cycle compared to the untreated cultures. This effect was less pronounced, but statistically significant, in the cultures treated 4 and 2 h before schizogony, whereas cultures in which Ned-19 was added at the moment of schizogony showed no difference compared to the DMSO-treated controls. The partial effect observed at the time points immediately preceding schizogony may however be explained by the fact that the 3 h synchronization window used in this experiment would allow some of the parasites to reach the Ned-19 insensitive schizont stage at these time points. This experiment in conclusion confirms that Ned-19 alters the transition from late trophozoite to early schizont and the subsequent parasite maturation into a mature schizont, while it does not affect egress of the merozoites or their ability to reinvade uninfected red blood cells.
Fig. 3

Ned-19 activity on the late phase of the asexual cycle of P. falciparum. Left asexual P. falciparum cultures were synchronized (initial parasitaemia 1.2%) and trophozoites at 32 h post invasion were incubated with DMSO (blue line) or 100 μM Ned-19 (red line) at the indicated time-points. Right parasitaemia and asexual stages of the cultures 2 h after merozoite egress (determined in the DMSO treated culture). N = 2. *p < 0.05; **p < 0.01. Error bar range/2

To investigate effects of Ned-19 treatment on parasite morphology, late asexual parasites were treated with 62.5 or 125 μM Ned-19 and examined through Giemsa staining and electron microscopy after 6 h of incubation. Examination by light microscopy revealed an aberrant morphology of the late parasite stages, characterized by presence of unstained vacuoles or nuclei with abnormal morphology. These features were present in 48 and 60% of the parasites in the 62.5 μM and the 125 μM treatments, respectively (Additional file 1: Figure S1).

Ned-19 localizes to acidic compartments in P. falciparum

Ned-19 is a fluorescent compound and this property has been exploited to label and subcellularly localize the NAADP receptors [25]. To investigate the presence and subcellular localization of putative NAADP receptors in P. falciparum, live parasites incubated with 200 μM Ned-19 were examined by fluorescence microscopy. Results showed that Ned-19 fluorescence exhibited a diffuse pattern in the different stages of the asexual cycle and in gametocytes (Fig. 4a).
Fig. 4

Ned-19 colocalizes with Lysotracker in asexual and sexual parasites. a Parasites stained with 200 μM Ned-19. b Parasites stained with 1 μM Lysotracker. c Parasites stained with 200 μM Ned-19 and 1 μM Lysotracker. BF bright field. Scale bar 5 μm

As Ned-19 localizes to acidic lysosome-like organelles in other cell types, Lysotracker Green DND-26, a dye marking membranes of acidic organelles, was used in co-localization experiments with Ned-19 (Fig. 4b, c). In this experiment a similar subcellular pattern of the Lysotracker and the Ned-19 fluorescence signals in both asexual and sexual parasites was observed, suggesting that Ned-19 accumulates in Lysotracker-positive compartments in P. falciparum. This may lead to speculate that putative parasite NAADP receptor(s) may localize in acidic compartments within the parasite, similarly to other organisms [36].

Ned-19 inhibits spontaneous Ca2+ oscillations in early ring and early trophozoite stages

To determine whether Ned-19 affects Ca2+ homeostasis in P. falciparum, spontaneous oscillations in intracellular Ca2+ concentration [6, 37] were measured incubating synchronized early ring and early trophozoite stages loaded with the calcium indicator Fura-2-AM in the presence or absence of 100 μM Ned-19. Oscillations in the intensity of the fluorescent signals were observed in treated and untreated parasites and the respective average peak heights were calculated, with values normalized to the minimum value in each measurement (Fig. 5a). R/Rmin−1 for untreated early rings and trophozoites were 0.0202 (SEM 4.64 × 10−4) and 0.0267 (SEM 1.02 × 10−3) respectively, whereas in the Ned-19 treated parasites values were 0.01526 (SEM 3.82 × 10−4) and 0.02177 (SEM 9.14 × 10−4) for early rings and for early trophozoites, respectively. The significantly smaller oscillations observed in the treated ring and trophozoite stages (p < 0.0001 and p = 0.0029, respectively) (Fig. 5b) indicate that spontaneous oscillations in free Ca2+ concentration are affected by Ned-19, supporting a specific effect of Ned-19 in P. falciparum Ca2+ regulation.
Fig. 5

Ned-19 inhibits spontaneous calcium oscillations in P. falciparum early rings and early trophozoites. a Representative traces of spontaneous calcium oscillations in early rings (ER) and early trophozoites (ET) in the presence of Ned-19 or vehicle DMSO. b Bar charts showing the average peak height of the spontaneous calcium oscillations in Ned-19 treated early rings (ER) or early trophozoites (ET) compared to controls. **p < 0.01; ****p < 0.0001. Error bar SEM

Discussion

This study investigated for the first time the effect of the NAADP antagonist Ned-19 on P. falciparum development, revealing that this compound inhibits the parasite asexual cycle and suggesting a potential role of NAADP in regulating P. falciparum Ca2+ signalling.

While the effects of inositol 1,4,5-bisphosphate (IP3)-induced [22, 23], cyclic ADP-ribose (cADPR) and ATP-induced [38] Ca2+ release have been previously described in P. falciparum [24] and in Toxoplasma gondii [39], the role of NAADP in this process and in parasite physiology has never been investigated in apicomplexan parasites. Moreover, the receptors involved in second messenger-induced Ca2+ release are unknown, since the orthologue of both IP3 receptors (IP3Rs) and ryanodine receptors (RyRs) have not been identified and two pore channels (TPCs) NAADP-receptor homologous sequences have not been found in the genome of P. falciparum [40]. Results of the present work show that a highly specific inhibitor of NAADP-induced Ca2+ release (Ned-19) blocks the transition from early to late trophozoite stages and schizont maturation in P. falciparum, supporting the notion that Ca2+ signalling plays a crucial role in different stages of P. falciparum asexual cycle. This supports previous findings [6] describing a pivotal role of Ca2+ signalling in the development of P. falciparum. In that study, the stage-specific spontaneous Ca2+ oscillations in the intra-erythrocytic stages of P. falciparum were inhibited by a specific inhibitor of IP3 (2-APB), resulting in developmental defects and leading to parasite death [6]. Interestingly, in that report and in the present work, the decrease in Ca2+ oscillations caused by 2-APB and Ned-19 at the early ring stage was not sufficient to block parasite development, while ability to affect Ca2+ oscillations later at the trophozoite stage was in both cases associated to an inhibitory effect on the growth of these parasites. The ability of Ca2+ signalling in regulating cellular response in different stages of parasite life cycle relies on a family of Ca2+-dependent protein kinases. Among these, PfCDPK1 (calcium-dependent protein kinase-1) is expressed during the intraerythrocytic schizogony and in the sporozoite stage, and it is crucial for the viability of P. falciparum. Kato and co-workers identified purkalfamine as an inhibitor of PfCDPK1 able to block parasite development at the late schizont stage [41]. It is known that CDPK1 is crucial also in the sexual life cycle stages of Plasmodium berghei, regulating zygote development [42]. Other studies showed that another Ca2+-dependent protein kinase, PfCDPK5, controls parasite egress from erythrocytes [43].

These data altogether highlight the potential impact of Ca2+ signalling antagonists as new antimalarial drugs able to block different stages of the life cycle of P. falciparum. Accordingly, different research groups recently focused their efforts in performing large scale drug screening to identify new compounds able to target Ca2+-dependent protein kinases or more generally Ca2+-signalling in Apicomplexa [4446]. In this context, the results of this study introduce NAADP signalling as a new potential target for the development of drugs able to impair Ca2+ homeostasis in P. falciparum.

Spontaneous Ca2+ oscillations have been poorly investigated in P. falciparum. It has been shown that a specific inhibitor of IP3 (2-APB) was able to block Ca2+ oscillations in ring and trophozoite stages [6], while a selective melatonin receptor antagonist, luzindole, was able to inhibit spontaneous Ca2+ oscillations mainly in the ring stages of the parasite [37]. The result that Ned-19 affects Ca2+ oscillations in early rings and trophozoites suggests that both NAADP and IP3 are involved in this process. This result is consistent with the observations that NAADP induces Ca2+ oscillations in different eukaryotic cell types, from sea urchin eggs [19] to pancreatic acinar cells [4749], through a two-pool mechanism involving both endoplasmic reticulum-independent NAADP-sensitive stores and the endoplasmic reticulum IP3- and cADPR-sensitive stores [50, 51]. In this model, NAADP is crucial in priming Ca2+-induced Ca2+-Release from endoplasmic reticulum (CICR), through a mechanism of overloading and spontaneous Ca2+ release from these stores [50].

Besides using Ned-19 as a specific inhibitor of NAADP signalling, this compound was used to fluorescently tag the NAADP receptor in living cells [25]. These experiments showed the co-localization of the Ned-19 and the Lysotracker fluorescent signals in different stages of the life cycle of P. falciparum, suggesting that yet to be identified NAADP-receptors may localize on acidic compartments also in P. falciparum and possibly in Apicomplexa, similarly to several mammalian cell types [18, 20]. As however different acidic organelles are labelled by Lysotracker dye in P. falciparum (acidocalcisomes, digestive vacuole and lysosomes), further experiments are needed to identity the Ned-19 positive organelles.

Conclusion

The ability of the specific NAADP inhibitor Ned-19 to block P. falciparum life cycle progression from the trophozoite to the late asexual stages and to affect spontaneous oscillations in the parasite intracellular Ca2+ concentration constitute the first evidence to suggest the presence of the regulatory molecule NAADP and its role in Ca2+ homeostasis in the malaria parasites and more generally in Apicomplexa. The lack of predicted orthologue NAADP receptors in the P. falciparum genome suggests that such putative receptors and the NAADP mediated regulatory mechanism(s) in the malaria parasites may considerably differ from those described in distant organisms. This raises the possibility that these yet to be explored cellular mechanism(s) may be targeted with a high selectivity.

Notes

Abbreviations

Ca2+

calcium

ATPase: 

adenosine triphosphatase

PPase: 

pyrophosphatase

SERCA: 

sarco/endoplasmic reticulum Ca2+-ATPase

IP3: 

inositol 1,4,5-bisphosphate

cADPR: 

cyclic ADP-ribose

NAADP: 

nicotinic acid adenine dinucleotide phosphate

TPCs: 

two pore channels

vWF: 

von Willebrand factor

ET-1: 

endothelin-1

DMSO: 

dimethyl sulfoxide

ROI: 

region of interest

SEM: 

standard error mean

IP3R: 

IP3 receptor

RyR: 

ryanodine receptor

PfCDPK1: 

calcium-dependent protein kinase-1

CICR: 

Ca2+-induced Ca2+-release

ER: 

early rings

LR: 

late rings

ET: 

early trophozoites

LT: 

late trophozoites

ES: 

early schizonts

LS: 

late schizonts

Declarations

Authors’ contributions

PSC and GG designed and conducted the experiments and drafted the manuscript. AF contributed to design calcium oscillation experiments. FP prepared and analyzed electron micrographs, contributed to design experiments and discussed the manuscript. PA and AF contributed to the experimental design and discussed the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank Dr. M. Sanchez, Istituto Superiore di Sanità, Rome, for FACS analysis and Prof. G. Girelli, Blood Centre of ‘Sapienza’ University of Rome, for the gift of human red blood cells.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethical approval and consent to participate

Not applicable.

Funding

This work was supported in part by the EU FP7 Network of Excellence ‘European Virtual Institute of Malaria Research EVIMalaR’ (Project No. 242095), the EU FP7 Project ‘OzMalNet’ (Project No. 269238) and the Bill and Melinda Gates Foundation Grant OPP1040394.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Dipartimento di Malattie Infettive, Istituto Superiore di Sanità
(2)
Department of Vector Biology, Max-Planck Institute for Infection Biology
(3)
Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Section of Histology and Medical Embryology, Sapienza University of Rome
(4)
Nucleic Acids Laboratory, Institute of Molecular Biology and Pathology, National Research Council (IBPM-CNR), Department of Biology and Biotechnologies, Sapienza University

References

  1. WHO. World malaria report 2016. Geneva: World Health Organization, 2016.Google Scholar
  2. Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med. 2013;19:156–67.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Wasserman M, Alarcon C, Mendoza PM. Effects of Ca ++ depletion on the asexual cell cycle of Plasmodium falciparum. Am J Trop Med Hyg. 1982;31:711–7.View ArticlePubMedGoogle Scholar
  4. Wasserman M, Chaparro J. Intraerythrocytic calcium chelators inhibit the invasion of Plasmodium falciparum. Parasitol Res. 1996;82:102–7.View ArticlePubMedGoogle Scholar
  5. Glushakova S, Lizunov V, Blank PS, Melikov K, Humphrey G, Zimmerberg J. Cytoplasmic free Ca2+ is essential for multiple steps in malaria parasite egress from infected erythrocytes. Malar J. 2013;12:41.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Enomoto M, Kawazu S, Kawai S, Furuyama W, Ikegami T, Watanabe J, et al. Blockage of spontaneous Ca2+ oscillation causes cell death in intraerythrocitic Plasmodium falciparum. PLoS ONE. 2012;7:e39499.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Docampo R, Moreno SN. Acidocalcisomes. Cell Calcium. 2011;50:113–9.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Biagini GA, Bray PG, Spiller DG, White MR, Ward SA. The digestive food vacuole of the malaria parasite is a dynamic intracellular Ca2+ store. J Biol Chem. 2003;278:27910–5.View ArticlePubMedGoogle Scholar
  9. Krishna S, Woodrow C, Webb R, Penny J, Takeyasu K, Kimura M, et al. Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J Biol Chem. 2001;276:10782–7.View ArticlePubMedGoogle Scholar
  10. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003;424:957–61.View ArticlePubMedGoogle Scholar
  11. Scheibel LW, Colombani PM, Hess AD, Aikawa M, Atkinson CT, Milhous WK. Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design. Proc Natl Acad Sci USA. 1987;84:7310–4.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Streb H, Irvine RF, Berridge MJ, Schulz I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature. 1983;306:67–9.View ArticlePubMedGoogle Scholar
  13. Lee HC, Walseth TF, Bratt GT, Hayes RN, Clapper DL. Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+-mobilizing activity. J Biol Chem. 1989;264:1608–15.PubMedGoogle Scholar
  14. Lee HC, Aarhus R. A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem. 1995;270:2152–7.View ArticlePubMedGoogle Scholar
  15. Albrieux M, Lee HC, Villaz M. Calcium signaling by cyclic ADP-ribose, NAADP, and inositol trisphosphate are involved in distinct functions in ascidian oocytes. J Biol Chem. 1998;273:14566–74.View ArticlePubMedGoogle Scholar
  16. Santella L, Kyozuka K, Genazzani AA, De Riso L, Carafoli E. Nicotinic acid adenine dinucleotide phosphate-induced Ca(2+) release. Interactions among distinct Ca(2+) mobilizing mechanisms in starfish oocytes. J Biol Chem. 2000;275:8301–6.View ArticlePubMedGoogle Scholar
  17. Navazio L, Bewell MA, Siddiqua A, Dickinson GD, Galione A, Sanders D. Calcium release from the endoplasmic reticulum of higher plants elicited by the NADP metabolite nicotinic acid adenine dinucleotide phosphate. Proc Natl Acad Sci USA. 2000;97:8693–8.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Aley PK, Mikolajczyk AM, Munz B, Churchill GC, Galione A, Berger F. Nicotinic acid adenine dinucleotide phosphate regulates skeletal muscle differentiation via action at two-pore channels. Proc Natl Acad Sci USA. 2010;107:19927–32.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Cancela JM, Churchill GC, Galione A. Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature. 1999;398:74–6.View ArticlePubMedGoogle Scholar
  20. Esposito B, Gambara G, Lewis AM, Palombi F, D’Alessio A, Taylor LX, et al. NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells. Blood. 2011;117:4968–77.View ArticlePubMedGoogle Scholar
  21. Gambara G, Billington RA, Debidda M, D’Alessio A, Palombi F, Ziparo E, et al. NAADP-induced Ca2+signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. J Cell Physiol. 2008;216:396–404.View ArticlePubMedGoogle Scholar
  22. Alves E, Bartlett PJ, Garcia CR, Thomas AP. Melatonin and IP3-induced Ca2+ release from intracellular stores in the malaria parasite Plasmodium falciparum within infected red blood cells. J Biol Chem. 2011;286:5905–12.View ArticlePubMedGoogle Scholar
  23. Garcia CRS, Alves E, Pereira PHS, Bartlett PJ, Thomas AP, Mikoshiba K, et al. InsP3 signaling in apicomplexan parasites. Curr Top Med Chem. 2017;17:2158–65.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Jones ML, Cottingham C, Rayner JC. Effects of calcium signaling on Plasmodium falciparum erythrocyte invasion and post-translational modification of gliding-associated protein 45 (PfGAP45). Mol Biochem Parasitol. 2009;168:55–62.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, et al. Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol. 2009;5:220–6.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Thai TL, Churchill GC, Arendshorst WJ. NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am J Physiol Renal Physiol. 2009;297:F510–6.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Arndt L, Castonguay J, Arlt E, Meyer D, Hassan S, Borth H, et al. NAADP and the two-pore channel protein 1 participate in the acrosome reaction in mammalian spermatozoa. Mol Biol Cell. 2014;25:948–64.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Davis LC, Morgan AJ, Chen JL, Snead CM, Bloor-Young D, Shenderov E, et al. NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing. Curr Biol. 2012;22:2331–7.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Favia A, Desideri M, Gambara G, D’Alessio A, Ruas M, Esposito B, et al. VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling. Proc Natl Acad Sci USA. 2014;111:E4706–15.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987;236:1661–6.View ArticlePubMedGoogle Scholar
  31. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418–20.View ArticlePubMedGoogle Scholar
  32. Nillni EA, Londner MV, Spira DT. A simple method for separation of uninfected erythrocytes from those infected with Plasmodium berghei and for isolation of artificially released parasites. Z Parasitenkd. 1981;64:279–84.View ArticlePubMedGoogle Scholar
  33. Bei AK, Desimone TM, Badiane AS, Ahouidi AD, Dieye T, Ndiaye D, et al. A flow cytometry-based assay for measuring invasion of red blood cells by Plasmodium falciparum. Am J Hematol. 2010;85:234–7.View ArticlePubMedPubMed CentralGoogle Scholar
  34. O’Haver T. Peak finding and measurement. https://de.mathworks.com/matlabcentral/fileexchange/11755-peak-finding-and-measurement (2006). Accessed 10 Jul 2016.
  35. Rosen D, Lewis AM, Mizote A, Thomas JM, Aley PK, Vasudevan SR, et al. Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist Ned-19 indicate two binding sites on the NAADP receptor. J Biol Chem. 2009;284:34930–4.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Galione A, Morgan AJ, Arredouani A, Davis LC, Rietdorf K, Ruas M, et al. NAADP as an intracellular messenger regulating lysosomal calcium-release channels. Biochem Soc Trans. 2010;38:1424–31.View ArticlePubMedGoogle Scholar
  37. Furuyama W, Enomoto M, Mossaad E, Kawai S, Mikoshiba K, Kawazu S. An interplay between 2 signaling pathways: melatonin-cAMP and IP3-Ca2+ signaling pathways control intraerythrocytic development of the malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun. 2014;446:125–31.View ArticlePubMedGoogle Scholar
  38. Cruz LN, Juliano MA, Budu A, Juliano L, Holder AA, Blackman MJ, et al. Extracellular ATP triggers proteolysis and cytosolic Ca(2)(+) rise in Plasmodium berghei and Plasmodium yoelii malaria parasites. Malar J. 2012;11:69.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Nagamune K, Hicks LM, Fux B, Brossier F, Chini EN, Sibley LD. Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii. Nature. 2008;451:207–10.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Plattner H, Sehring IM, Mohamed IK, Miranda K, De Souza W, Billington R, et al. Calcium signaling in closely related protozoan groups (Alveolata): non-parasitic ciliates (Paramecium, Tetrahymena) vs. parasitic Apicomplexa (Plasmodium, Toxoplasma). Cell Calcium. 2012;51:351–82.View ArticlePubMedGoogle Scholar
  41. Kato N, Sakata T, Breton G, Le Roch KG, Nagle A, Andersen C, et al. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nat Chem Biol. 2008;4:347–56.View ArticlePubMedGoogle Scholar
  42. Sebastian S, Brochet M, Collins MO, Schwach F, Jones ML, Goulding D, et al. A Plasmodium calcium-dependent protein kinase controls zygote development and transmission by translationally activating repressed mRNAs. Cell Host Microbe. 2012;12:9–19.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Dvorin JD, Martyn DC, Patel SD, Grimley JS, Collins CR, Hopp CS, et al. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science. 2010;328:910–2.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Crowther GJ, Hillesland HK, Keyloun KR, Reid MC, Lafuente-Monasterio MJ, Ghidelli-Disse S, et al. Biochemical screening of five protein kinases from Plasmodium falciparum against 14,000 cell-active compounds. PLoS ONE. 2016;11:e0149996.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Hui R, El Bakkouri M, Sibley LD. Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans. Trends Pharmacol Sci. 2015;36:452–60.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Sidik SM, Hortua Triana MA, Paul AS, El Bakkouri M, Hackett CG, Tran F, et al. Using a genetically encoded sensor to identify inhibitors of Toxoplasma gondii Ca2+ signaling. J Biol Chem. 2016;291:9566–80.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Aarhus R, Dickey DM, Graeff RM, Gee KR, Walseth TF, Lee HC. Activation and inactivation of Ca2+ release by NAADP+. J Biol Chem. 1996;271:8513–6.View ArticlePubMedGoogle Scholar
  48. Genazzani AA, Empson RM, Galione A. Unique inactivation properties of NAADP-sensitive Ca2+ release. J Biol Chem. 1996;271:11599–602.View ArticlePubMedGoogle Scholar
  49. Genazzani AA, Galione A. Nicotinic acid-adenine dinucleotide phosphate mobilizes Ca2+ from a thapsigargin-insensitive pool. Biochem J. 1996;315(Pt 3):721–5.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Churchill GC, Galione A. NAADP induces Ca2+ oscillations via a two-pool mechanism by priming IP3- and cADPR-sensitive Ca2+ stores. EMBO J. 2001;20:2666–71.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Guse AH. Linking NAADP to ion channel activity: a unifying hypothesis. Sci Signal. 2012;5:pe18.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement